FDA issues software guidance

Article

The FDA has released the first draft of a guideline for good manufacturingpractices for computerized medical devices. The guideline willapply to the manufacturers of all computerized medical products,including computed tomography and magnetic resonance

The FDA has released the first draft of a guideline for good manufacturingpractices for computerized medical devices. The guideline willapply to the manufacturers of all computerized medical products,including computed tomography and magnetic resonance imaging.

The agency will determine whether to finalize the guidelineafter a period of industry comments. If the FDA decides to proceed,it will modify the guidance on the basis of those comments, saidW. Fred Hooten, director of the FDA division of compliance programs,office of compliance and surveillance.

The guideline is called the "Application of the medicaldevice GMPs to computerized devices and manufacturing processes--medicaldevice GMP guidance for FDA investigators." Its purpose isto assist agency field operatives in their inspections of manufacturingfacilities.

In addition to covering products, the draft guideline coverssoftware and hardware intended to control automated device manufacturingprocesses, including quality assurance and record keeping. Theguidance does not contain instructions on how to validate software.

"We would like to see the industry associations--HIMAand NEMA--develop some software validation guidance rather thanour doing it," Hooten said. "They are the ones who aremost knowledgeable in that area."

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.